| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000002360 |
| Receipt No. | R000002898 |
| Official scientific title of the study | Efficacy of Montelukast to prolonged cough. |
| Date of disclosure of the study information | 2009/08/21 |
| Last modified on | 2017/08/23 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Efficacy of Montelukast to prolonged cough. | |
| Title of the study (Brief title) | Efficacy of Montelukast to prolonged cough. | |
| Region |
|
|
| Condition | ||||||||||
| Condition | prolonged cough | |||||||||
| Classification by specialty |
|
|||||||||
| Classification by malignancy | Others | |||||||||
| Genomic information | NO | |||||||||
| Objectives | |
| Narrative objectives1 | Efficacy of anti-inflammatory drugs (Fluticason propionate or Montelukast)to patients of prolonged cough at early phase use. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Change rate of cough score. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Fluticason propionate is administrated. | |
| Interventions/Control_2 | Montelukast is administrated. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1, Sex and age : No object.
2, Hospitalization or out patients : No object. 3, Non-smoking patient (By prohibition of smoking and past history of cigarette smoking include a smoking patient within 10pack-year more than three months). 4, Prolonged and/or chronic cough was continuing more than three weeks. 5, The patient who was able to acquire an agreement by the document. |
|||
| Key exclusion criteria | 1, Patients with the shadow by chest X-rays.
2, Patients who heard fine crackle. 3, Patients that consultation two weeks later is impossible. 4, Patients who give a clear asthma attack. 5, Patients who merges heart failure. 6, Patients who is running a fever. 7, Patients who is infected with serious respiratory illnesses such as activity-related tuberculosis or lung cancer. 8, ACE inhibitor taking patients. 9, Side effect that is serious for an ingredient of the study medicine or a patient with the anamnesis of the erythrism. 10,Patients whom it was judged a doctor not to be suitable as an object of the studies. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Tohda, Yuji |
| Organization | Kinki University |
| Division name | Respiratory medicine and allergology |
| Address | Osakasayama-shi, Osaka |
| TEL | |
| Public contact | |
| Name of contact person | |
| Organization | Kinki University |
| Division name | Respiratory medicine and allergology |
| Address | |
| TEL | |
| Homepage URL | |
| Sponsor | |
| Institute | Kansai Asthma Research Network(KARN) |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Allergy Foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002898 |